Defective ALG11 causes ALG11-CDG (CDG-1p)

Stable Identifier
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser

GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (ALG11) transfers the fourth and fifth mannoses (Man) to the N-glycan precursor in an alpha-1,2 orientation. These additions are the last two on the cytosolic side of the ER membrane before the N-glycan is flipped to the luminal side of the membrane. Recently discovered defects in ALG11 have been linked to congential disorder of glycosylation, type 1p (ALG11-CDG, CGD1p) (Rind et al. 2010, Thiel et al. 2012). The disease is a multi-system disorder characterised by under-glycosylated serum glycoproteins. Early-onset developmental retardation, dysmorphic features, hypotonia, coagulation disorders and immunodeficiency are reported features of this disorder (Rind et al. 2010, Thiel et al. 2012).

Literature References
PubMed ID Title Journal Year
22213132 Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip

Thiel, C, Rind, N, Popovici, D, Hoffmann, GF, Hanson, K, Conway, RL, Adamski, CR, Butler, E, Scanlon, R, Lambert, M, Apeshiotis, N, Thiels, C, Matthijs, G, Körner, C

Hum. Mutat. 2012
20080937 A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip

Rind, N, Schmeiser, V, Thiel, C, Absmanner, B, Lübbehusen, J, Hocks, J, Apeshiotis, N, Wilichowski, E, Lehle, L, Körner, C

Hum. Mol. Genet. 2010
Cite Us!